Eli Lilly drops Canadian Mounjaro, Zepbound list prices to $300 for starting doses
Chronic pain, drug gaps and gender bias drive rising disability risk for plans
Nearly 2 in 3 online users now report recurring digital burnout as it drains focus
Pension and benefit investors pivot toward home-market bonds and equities
CPP Investments ramps up Canadian industrial exposure with $3 billion acquisition platform
Wealthy investors join insurers in backing PIMCO’s growing private credit platform
Investors face tighter US scrutiny on ESG and diversity votes
Rising costs push retirees to juggle cash flow, work and home equity to stay afloat
TRC takeover tightens Canadian pension grip on long-term energy demand
Fund manager argues overlooked Canadian mid-caps now offer better odds than banks and big tech
